Are there non-steroid-dependent rejection episodes?
- PMID: 7017680
Are there non-steroid-dependent rejection episodes?
Abstract
We undertook two randomised studies in an effort to decrease the dosage of steroids in transplanted patients and to replace harmful steroid therapy by nonsteroid anti-inflammatory (NSAI) drugs. In the first study, 50 consecutive transplant recipients were randomly assigned to the treatment or the control group. In both groups, patients received azathioprine and prednisolone. ATG was added to this protocol in the experimental group. The number of renal failure episodes and consequently the amount of steroid necessary to control these episodes were significantly lower in the ATG group than in the other group. Two year post-transplantation kidney survival was 79% in the ATG group and 52% in the control group. In the second study, 15 consecutive transplant recipients were randomly assigned to two control groups and to one experimental group, where steroids were replaced by NSAI drugs. This preliminary, and very limited, pilot trial demonstrates the existence of early acute renal failure episodes, probably of immunological origin, which can improve spontaneously in the absence of steroid therapy.
Similar articles
-
Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.Chin Med J (Engl). 2006 Oct 20;119(20):1683-8. Chin Med J (Engl). 2006. PMID: 17097014
-
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.Clin Transplant. 1995 Oct;9(5):406-14. Clin Transplant. 1995. PMID: 8541635 Clinical Trial.
-
Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.Iran J Kidney Dis. 2008 Jan;2(1):34-9. Iran J Kidney Dis. 2008. PMID: 19367007 Clinical Trial.
-
One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.Transplant Proc. 2007 Jan-Feb;39(1):69-72. doi: 10.1016/j.transproceed.2006.10.007. Transplant Proc. 2007. PMID: 17275476
-
Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.Clin Nephrol. 1996 Jan;45(1):22-8. Clin Nephrol. 1996. PMID: 8616953
Cited by
-
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2. Cochrane Database Syst Rev. 2017. PMID: 28073178 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical